EyePoint Pharmaceuticals, Inc.EyePoint Pharmaceuticals, Inc.EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

34.360.000.00%
The 11 analysts offering 1 year price forecasts for EYPT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 12 analysts giving stock ratings to EYPT in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


EYPT EPS for the last quarter is −0.54 USD despite the estimation of −0.55 USD. In the next quarter EPS is expected to reach −0.54 USD. Track more of EyePoint Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter EyePoint Pharmaceuticals, Inc. revenue is expected to reach ‪10.08 M‬ USD. Check out EyePoint Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, EYPT price target is 34.36 USD with a max estimate of 68.00 USD and a min estimate of 18.00 USD. Check if this forecast comes true in a year, meanwhile watch EyePoint Pharmaceuticals, Inc. stock price chart and keep track of the current situation with EYPT news and stock market news.
We've gathered opinions of 12 analysts rating EYPT stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.